From the perspective of cost-effectiveness and safety, HES is much more suitable as a pharmacologic strategy for OHSS prevention compared with albumin, but more evidence should be sought prior to the generalised routine use of this drug. Here, ALB is linked to ovarian hyperstimulation syndrome.